Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The American Society of Clinical Oncology (ASCO) 2020 annual congress scheduled for May 29-June 2 in Chicago, will be replaced by a virtual edition.

ASCO 2020

29 May–02 June 2020 | Virtual Meeting

ASCO 2020

29 May–02 June 2020 | Virtual Meeting

The American Society of Clinical Oncology (ASCO) 2020 annual congress scheduled for May 29-June 2 in Chicago, will be replaced by a virtual edition.

EHA and ASCO 2020 – what data will impact clinical practice? 4:32
EHA and ASCO 2020 – what data will impact clinical practice?
Joshua Richter • 7 Jul 2020
Defining newly diagnosed high-risk MM 3:08
Defining newly diagnosed high-risk MM
Joshua Richter • 7 Jul 2020
David C. Fajgenbaum: Chasing My Cure 8:40
David C. Fajgenbaum: Chasing My Cure
David C. Fajgenbaum • 1 Jun 2020
Safety and efficacy of allogeneic CAR-T cell treatment 2:53
Safety and efficacy of allogeneic CAR-T cell treatment
Sattva Neelapu • 29 May 2020
ZUMA-1: safety and efficacy of axicabtagene in refractory non-Hodgkin lymphoma patients 2:48
ZUMA-1: safety and efficacy of axicabtagene in refractory non-Hodgkin lymphoma patients
Sattva Neelapu • 29 May 2020
Combining hypomethylating agents in AML 5:08
Combining hypomethylating agents in AML
Amer Zeidan • 1 Jun 2020
Significance of oral hypomethylating agents 3:51
Significance of oral hypomethylating agents
Amer Zeidan • 1 Jun 2020
Hypomethylating agents in AML 3:08
Hypomethylating agents in AML
Amer Zeidan • 1 Jun 2020
Highlights in multiple myeloma at ASCO 2020 9:58
Highlights in multiple myeloma at ASCO 2020
Thomas Martin • 1 Jun 2020
Updates from the MEDALIST study 3:58
Updates from the MEDALIST study
Amer Zeidan • 1 Jun 2020
Glasdegib in combination with azacitidine in MDS, AML and CMML 3:32
Glasdegib in combination with azacitidine in MDS, AML and CMML
Amer Zeidan • 1 Jun 2020
ASCO 2020: BiTEs in multiple myeloma 9:42
ASCO 2020: BiTEs in multiple myeloma
Thomas Martin • 1 Jun 2020
KarMMa: Idecabtagene vicleucel for R/R MM 5:34
KarMMa: Idecabtagene vicleucel for R/R MM
Nikhil Munshi • 1 Jun 2020
Venetoclax plus dose-adjusted R-EPOCH for Richter’s syndrome 3:08
Venetoclax plus dose-adjusted R-EPOCH for Richter’s syndrome
Matthew Davids • 1 Jun 2020
ALPHA trial: ALLO-501 in relapsed/refractory non-Hodgkin lymphoma 3:07
ALPHA trial: ALLO-501 in relapsed/refractory non-Hodgkin lymphoma
Sattva Neelapu • 29 May 2020
COVID-19 in Wisconsin, USA 3:21
COVID-19 in Wisconsin, USA
Nirav Niranjan Shah • 18 May 2020

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals